appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Venmax Drugs and Pharmaceuticals Ltd
VENMAX
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Venmax Drugs and Pharmaceuticals Limited is an India-based company engaged in manufacturing of pharmaceuticals and drugs. The Company is in the business of trading of bulk drugs, intermediates and biotech products.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Board Meeting
Venmax Drugs And Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31St December 2024. | Download
Venmax Drugs And Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31St December 2024. | Download
Company Update
Venmax Drugs And Pharmaceuticals Ltd - 531015 - We Would Like To Inform You That The Extra-Ordinary General Meeting Is Schedule To Be Held On Thursday, February 06, 2025, At 12:00 PM Through Video Conferencing Or Other Audio Visual Means ("OAVM"). | Download
Venmax Drugs And Pharmaceuticals Ltd - 531015 - We Would Like To Inform You That The Extra-Ordinary General Meeting Is Schedule To Be Held On Thursday, February 06, 2025, At 12:00 PM Through Video Conferencing Or Other Audio Visual Means ("OAVM"). | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant